GSK

$49.91

117 put contracts · delayed quotes via cboe · fetched 5:26 AM ET

GSK is below a rising 200-day average. Below a rising long-term average — a deeper pullback, with the longer-term trend still intact.

Last: $49.91
200-day: $52.28
vs 200-day: -4.5%
50-day: $51.66
RSI (14): 43
52-week range: $39.52 – $61.18

The business

61/100Next earnings 2026-10-28

Selling a put is a commitment to buy, so this asks whether you would want the business at all — separately from whether the price looks good.

Size77$99.9B market cap

Cash flow61$3.5B free cash flow

Balance sheet681.06 debt/equity

Growth21earnings -69.5%, revenue 5.3%

Profitability84ROE 33.4%, margin 14.5%

Where the volume traded

Heaviest traded price is $51.43; 70% of volume changed hands between $45.64 and $57.97. The lookback matters — a shorter window weights recent trading more heavily.

spot $49.91

heaviest tradedspotyour break-evens252 sessions

0 contracts match your settings, ranked by fit

Excluded: 99 delta above range · 6 delta below range

Nothing matches these settings right now.

That is a result, not an error. Here is what ruled the contracts out:

99delta above range
6delta below range
6expiry too soon
5open interest too low
1expiry too far out

Your delta band for this stance is 0.18–0.36. Switching stance widens the delta band.

Credit uses the bid, not the mid — that is what a seller actually receives. Tap any contract for the full arithmetic.

Screen another symbol